Market Research Logo

Cancer Vaccines - Global Market Outlook (2016-2022)

Cancer Vaccines - Global Market Outlook (2016-2022)

According to Stratistics MRC, the Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients, increasing ageing population and awareness of vaccines are fueling the market. However, less availability of vaccines and advanced treatments in underdeveloped regions may limit the market growth.

North America accounted for the largest share in the market followed by Asia Pacific. The favourable growth is attributed to supportive government and other organisations such as World health organisation and GAVI initiatives.

Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited-P.P. Enterprises, Juvaris Biotherapeutics, Merk&co, Prima BioMed Ltd, Cytos Biotechnology AG, Ubivac, duro BioTech, AstraZeneca plc., and MedImmune, LLC.

Disease Indication Covered:
Cervical cancer
Esophageal cancer
Liver cancer
Prostate cancer
Lung cancer
Breast cancer
Stomach cancer

Technologies Covered:
Inactivated Vaccines
Peptide/protein vaccines
Synthetic Vaccines
Toxoid Vaccines
Live Attenuated Vaccines
Recombinant Vector Vaccines
Antigen vaccines
Dendritic Cell Vaccines
Subunit Vaccines
Heat shock protein vaccines
DNA- and vector-based vaccines
Conjugate Vaccines
Anti-idiotype vaccines
Cancer stem cell vaccines

End Users Covered:
Adults
Paediatrics

Vaccine Types Covered:
Therapeutic Vaccines
Preventive Vaccines

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cancer Vaccines Market, By Disease Indication
5.1 Introduction
5.2 Cervical cancer
5.3 Esophageal cancer
5.4 Liver cancer
5.5 Prostate cancer
5.6 Lung cancer
5.7 Breast cancer
5.8 Stomach cancer
6 Global Cancer Vaccines Market, By Technology
6.1 Introduction
6.2 Inactivated Vaccines
6.3 Peptide/protein vaccines
6.4 Synthetic Vaccines
6.5 Toxoid Vaccines
6.6 Live Attenuated Vaccines
6.7 Recombinant Vector Vaccines
6.8 Antigen vaccines
6.9 Dendritic Cell Vaccines
6.10 Subunit Vaccines
6.11 Heat shock protein vaccines
6.12 DNA- and vector-based vaccines
6.13 Conjugate Vaccines
6.14 Anti-idiotype vaccines
6.15 Cancer stem cell vaccines
7 Global Cancer Vaccines Market, By End User
7.1 Introduction
7.2 Adults
7.3 Pediatrics
8 Global Cancer Vaccines Market, By Vaccine Type
8.1 Therapeutic Vaccines
8.2 Preventive Vaccines
9 Global Cancer Vaccines Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Oxford BioMedica
11.2 Vaccinogen Inc.
11.3 GlaxoSmithKline
11.4 Sanofi India Limited-P.P. Enterprises
11.5 Juvaris Biotherapeutics
11.6 Merk&co
11.7 Prima BioMed Ltd
11.8 Cytos Biotechnology AG
11.9 Ubivac
11.10 duro BioTech
11.11 AstraZeneca plc
11.12 MedImmune, LLC
11.13 Nova Rx Corporation
11.14 Argos Therapeutics
11.15 Prima BioMed Ltd
List of Tables
Table 1 Global Cancer Vaccines Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Cancer Vaccines Market Outlook, By Disease Indication (2013-2022) ($MN)
Table 3 Global Cancer Vaccines Market Outlook, By Cervical cancer (2013-2022) ($MN)
Table 4 Global Cancer Vaccines Market Outlook, By Esophageal cancer (2013-2022) ($MN)
Table 5 Global Cancer Vaccines Market Outlook, By Liver cancer (2013-2022) ($MN)
Table 6 Global Cancer Vaccines Market Outlook, By Prostate cancer (2013-2022) ($MN)
Table 7 Global Cancer Vaccines Market Outlook, By Lung cancer (2013-2022) ($MN)
Table 8 Global Cancer Vaccines Market Outlook, By Breast cancer (2013-2022) ($MN)
Table 9 Global Cancer Vaccines Market Outlook, By Stomach cancer (2013-2022) ($MN)
Table 10 Global Cancer Vaccines Market Outlook, By Technology (2013-2022) ($MN)
Table 11 Global Cancer Vaccines Market Outlook, By Inactivated Vaccines (2013-2022) ($MN)
Table 12 Global Cancer Vaccines Market Outlook, By Peptide/protein vaccines (2013-2022) ($MN)
Table 13 Global Cancer Vaccines Market Outlook, By Synthetic Vaccines (2013-2022) ($MN)
Table 14 Global Cancer Vaccines Market Outlook, By Toxoid Vaccine (2013-2022) ($MN)
Table 15 Global Cancer Vaccines Market Outlook, By Live Attenuated Vaccines (2013-2022) ($MN)
Table 16 Global Cancer Vaccines Market Outlook, By Recombinant Vector Vaccines (2013-2022) ($MN)
Table 17 Global Cancer Vaccines Market Outlook, By Antigen vaccines(2013-2022) ($MN)
Table 18 Global Cancer Vaccines Market Outlook, By Dendritic Cell Vaccines (2013-2022) ($MN)
Table 19 Global Cancer Vaccines Market Outlook, By Subunit Vaccines (2013-2022) ($MN)
Table 20 Global Cancer Vaccines Market Outlook, By Heat shock protein vaccines (2013-2022) ($MN)
Table 21 Global Cancer Vaccines Market Outlook, By DNA- and vector-based vaccines (2013-2022) ($MN)
Table 22 Global Cancer Vaccines Market Outlook, By Conjugate Vaccines (2013-2022) ($MN)
Table 23 Global Cancer Vaccines Market Outlook, By Anti-idiotype vaccines (2013-2022) ($MN)
Table 24 Global Cancer Vaccines Market Outlook, By Cancer stem cell vaccines (2013-2022) ($MN)
Table 25 Global Cancer Vaccines Market Outlook, By End User (2013-2022) ($MN)
Table 26 Global Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 27 Global Cancer Vaccines Market Outlook, By Pediatrics (2013-2022) ($MN)
Table 28 Global Cancer Vaccines Market Outlook, By Vaccine Type (2013-2022) ($MN)
Table 29 Global Cancer Vaccines Market Outlook, By Therapeutic Vaccines (2013-2022) ($MN)
Table 30 Global Cancer Vaccines Market Outlook, By Preventive Vaccines (2013-2022) ($MN)
Table 31 Global Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 32 North America Cancer Vaccines Market Outlook, By Country (2013-2022) ($MN)
Table 33 North America Cancer Vaccines Market Outlook, By Disease Indication (2013-2022) ($MN)
Table 34 North America Cancer Vaccines Market Outlook, By Cervical cancer (2013-2022) ($MN)
Table 35 North America Cancer Vaccines Market Outlook, By Esophageal cancer (2013-2022) ($MN)
Table 36 North America Cancer Vaccines Market Outlook, By Liver cancer (2013-2022) ($MN)
Table 37 North America Cancer Vaccines Market Outlook, By Prostate cancer (2013-2022) ($MN)
Table 38 North America Cancer Vaccines Market Outlook, By Lung cancer (2013-2022) ($MN)
Table 39 North America Cancer Vaccines Market Outlook, By Breast cancer (2013-2022) ($MN)
Table 40 North America Cancer Vaccines Market Outlook, By Stomach cancer (2013-2022) ($MN)
Table 41 North America Cancer Vaccines Market Outlook, By Technology (2013-2022) ($MN)
Table 42 North America Cancer Vaccines Market Outlook, By Inactivated Vaccines (2013-2022) ($MN)
Table 43 North America Cancer Vaccines Market Outlook, By Peptide/protein vaccines (2013-2022) ($MN)
Table 44 North America Cancer Vaccines Market Outlook, By Synthetic Vaccines (2013-2022) ($MN)
Table 45 North America Cancer Vaccines Market Outlook, By Toxoid Vaccine (2013-2022) ($MN)
Table 46 North America Cancer Vaccines Market Outlook, By Live Attenuated Vaccines (2013-2022) ($MN)
Table 47 North America Cancer Vaccines Market Outlook, By Recombinant Vector Vaccines (2013-2022) ($MN)
Table 48 North America Cancer Vaccines Market Outlook, By Antigen vaccines(2013-2022) ($MN)
Table 49 North America Cancer Vaccines Market Outlook, By Dendritic Cell Vaccines (2013-2022) ($MN)
Table 50 North America Cancer Vaccines Market Outlook, By Subunit Vaccines (2013-2022) ($MN)
Table 51 North America Cancer Vaccines Market Outlook, By Heat shock protein vaccines (2013-2022) ($MN)
Table 52 North America Cancer Vaccines Market Outlook, By DNA- and vector-based vaccines (2013-2022) ($MN)
Table 53 North America Cancer Vaccines Market Outlook, By Conjugate Vaccines (2013-2022) ($MN)
Table 54 North America Cancer Vaccines Market Outlook, By Anti-idiotype vaccines (2013-2022) ($MN)
Table 55 North America Cancer Vaccines Market Outlook, By Cancer stem cell vaccines (2013-2022) ($MN)
Table 56 North America Cancer Vaccines Market Outlook, By End User (2013-2022) ($MN)
Table 57 North America Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 58 North America Cancer Vaccines Market Outlook, By Pediatrics (2013-2022) ($MN)
Table 59 North America Cancer Vaccines Market Outlook, By Vaccine Type (2013-2022) ($MN)
Table 60 North America Cancer Vaccines Market Outlook, By Therapeutic Vaccines (2013-2022) ($MN)
Table 61 North America Cancer Vaccines Market Outlook, By Preventive Vaccines (2013-2022) ($MN)
Table 62 North America Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 63 Europe Cancer Vaccines Market Outlook, By Country (2013-2022) ($MN)
Table 64 Europe Cancer Vaccines Market Outlook, By Disease Indication (2013-2022) ($MN)
Table 65 Europe Cancer Vaccines Market Outlook, By Cervical cancer (2013-2022) ($MN)
Table 66 Europe Cancer Vaccines Market Outlook, By Esophageal cancer (2013-2022) ($MN)
Table 67 Europe Cancer Vaccines Market Outlook, By Liver cancer (2013-2022) ($MN)
Table 68 Europe Cancer Vaccines Market Outlook, By Prostate cancer (2013-2022) ($MN)
Table 69 Europe Cancer Vaccines Market Outlook, By Lung cancer (2013-2022) ($MN)
Table 70 Europe Cancer Vaccines Market Outlook, By Breast cancer (2013-2022) ($MN)
Table 71 Europe Cancer Vaccines Market Outlook, By Stomach cancer (2013-2022) ($MN)
Table 72 Europe Cancer Vaccines Market Outlook, By Technology (2013-2022) ($MN)
Table 73 Europe Cancer Vaccines Market Outlook, By Inactivated Vaccines (2013-2022) ($MN)
Table 74 Europe Cancer Vaccines Market Outlook, By Peptide/protein vaccines (2013-2022) ($MN)
Table 75 Europe Cancer Vaccines Market Outlook, By Synthetic Vaccines (2013-2022) ($MN)
Table 76 Europe Cancer Vaccines Market Outlook, By Toxoid Vaccine (2013-2022) ($MN)
Table 77 Europe Cancer Vaccines Market Outlook, By Live Attenuated Vaccines (2013-2022) ($MN)
Table 78 Europe Cancer Vaccines Market Outlook, By Recombinant Vector Vaccines (2013-2022) ($MN)
Table 79 Europe Cancer Vaccines Market Outlook, By Antigen vaccines(2013-2022) ($MN)
Table 80 Europe Cancer Vaccines Market Outlook, By Dendritic Cell Vaccines (2013-2022) ($MN)
Table 81 Europe Cancer Vaccines Market Outlook, By Subunit Vaccines (2013-2022) ($MN)
Table 82 Europe Cancer Vaccines Market Outlook, By Heat shock protein vaccines (2013-2022) ($MN)
Table 83 Europe Cancer Vaccines Market Outlook, By DNA- and vector-based vaccines (2013-2022) ($MN)
Table 84 Europe Cancer Vaccines Market Outlook, By Conjugate Vaccines (2013-2022) ($MN)
Table 85 Europe Cancer Vaccines Market Outlook, By Anti-idiotype vaccines (2013-2022) ($MN)
Table 86 Europe Cancer Vaccines Market Outlook, By Cancer stem cell vaccines (2013-2022) ($MN)
Table 87 Europe Cancer Vaccines Market Outlook, By End User (2013-2022) ($MN)
Table 88 Europe Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 89 Europe Cancer Vaccines Market Outlook, By Pediatrics (2013-2022) ($MN)
Table 90 Europe Cancer Vaccines Market Outlook, By Vaccine Type (2013-2022) ($MN)
Table 91 Europe Cancer Vaccines Market Outlook, By Therapeutic Vaccines (2013-2022) ($MN)
Table 92 Europe Cancer Vaccines Market Outlook, By Preventive Vaccines (2013-2022) ($MN)
Table 93 Europe Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 94 Asia Pacific Cancer Vaccines Market Outlook, By Country (2013-2022) ($MN)
Table 95 Asia Pacific Cancer Vaccines Market Outlook, By Disease Indication (2013-2022) ($MN)
Table 96 Asia Pacific Cancer Vaccines Market Outlook, By Cervical cancer (2013-2022) ($MN)
Table 97 Asia Pacific Cancer Vaccines Market Outlook, By Esophageal cancer (2013-2022) ($MN)
Table 98 Asia Pacific Cancer Vaccines Market Outlook, By Liver cancer (2013-2022) ($MN)
Table 99 Asia Pacific Cancer Vaccines Market Outlook, By Prostate cancer (2013-2022) ($MN)
Table 100 Asia Pacific Cancer Vaccines Market Outlook, By Lung cancer (2013-2022) ($MN)
Table 101 Asia Pacific Cancer Vaccines Market Outlook, By Breast cancer (2013-2022) ($MN)
Table 102 Asia Pacific Cancer Vaccines Market Outlook, By Stomach cancer (2013-2022) ($MN)
Table 103 Asia Pacific Cancer Vaccines Market Outlook, By Technology (2013-2022) ($MN)
Table 104 Asia Pacific Cancer Vaccines Market Outlook, By Inactivated Vaccines (2013-2022) ($MN)
Table 105 Asia Pacific Cancer Vaccines Market Outlook, By Peptide/protein vaccines (2013-2022) ($MN)
Table 106 Asia Pacific Cancer Vaccines Market Outlook, By Synthetic Vaccines (2013-2022) ($MN)
Table 107 Asia Pacific Cancer Vaccines Market Outlook, By Toxoid Vaccine (2013-2022) ($MN)
Table 108 Asia Pacific Cancer Vaccines Market Outlook, By Live Attenuated Vaccines (2013-2022) ($MN)
Table 109 Asia Pacific Cancer Vaccines Market Outlook, By Recombinant Vector Vaccines (2013-2022) ($MN)
Table 110 Asia Pacific Cancer Vaccines Market Outlook, By Antigen vaccines(2013-2022) ($MN)
Table 111 Asia Pacific Cancer Vaccines Market Outlook, By Dendritic Cell Vaccines (2013-2022) ($MN)
Table 112 Asia Pacific Cancer Vaccines Market Outlook, By Subunit Vaccines (2013-2022) ($MN)
Table 113 Asia Pacific Cancer Vaccines Market Outlook, By Heat shock protein vaccines (2013-2022) ($MN)
Table 114 Asia Pacific Cancer Vaccines Market Outlook, By DNA- and vector-based vaccines (2013-2022) ($MN)
Table 115 Asia Pacific Cancer Vaccines Market Outlook, By Conjugate Vaccines (2013-2022) ($MN)
Table 116 Asia Pacific Cancer Vaccines Market Outlook, By Anti-idiotype vaccines (2013-2022) ($MN)
Table 117 Asia Pacific Cancer Vaccines Market Outlook, By Cancer stem cell vaccines (2013-2022) ($MN)
Table 118 Asia Pacific Cancer Vaccines Market Outlook, By End User (2013-2022) ($MN)
Table 119 Asia Pacific Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 120 Asia Pacific Cancer Vaccines Market Outlook, By Pediatrics (2013-2022) ($MN)
Table 121 Asia Pacific Cancer Vaccines Market Outlook, By Vaccine Type (2013-2022) ($MN)
Table 122 Asia Pacific Cancer Vaccines Market Outlook, By Therapeutic Vaccines (2013-2022) ($MN)
Table 123 Asia Pacific Cancer Vaccines Market Outlook, By Preventive Vaccines (2013-2022) ($MN)
Table 124 Asia Pacific Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 125 RoW Cancer Vaccines Market Outlook, By Country (2013-2022) ($MN)
Table 126 RoW Cancer Vaccines Market Outlook, By Disease Indication (2013-2022) ($MN)
Table 127 RoW Cancer Vaccines Market Outlook, By Cervical cancer (2013-2022) ($MN)
Table 128 RoW Cancer Vaccines Market Outlook, By Esophageal cancer (2013-2022) ($MN)
Table 129 RoW Cancer Vaccines Market Outlook, By Liver cancer (2013-2022) ($MN)
Table 130 RoW Cancer Vaccines Market Outlook, By Prostate cancer (2013-2022) ($MN)
Table 131 RoW Cancer Vaccines Market Outlook, By Lung cancer (2013-2022) ($MN)
Table 132 RoW Cancer Vaccines Market Outlook, By Breast cancer (2013-2022) ($MN)
Table 133 RoW Cancer Vaccines Market Outlook, By Stomach cancer (2013-2022) ($MN)
Table 134 RoW Cancer Vaccines Market Outlook, By Technology (2013-2022) ($MN)
Table 135 RoW Cancer Vaccines Market Outlook, By Inactivated Vaccines (2013-2022) ($MN)
Table 136 RoW Cancer Vaccines Market Outlook, By Peptide/protein vaccines (2013-2022) ($MN)
Table 137 RoW Cancer Vaccines Market Outlook, By Synthetic Vaccines (2013-2022) ($MN)
Table 138 RoW Cancer Vaccines Market Outlook, By Toxoid Vaccine (2013-2022) ($MN)
Table 139 RoW Cancer Vaccines Market Outlook, By Live Attenuated Vaccines (2013-2022) ($MN)
Table 140 RoW Cancer Vaccines Market Outlook, By Recombinant Vector Vaccines (2013-2022) ($MN)
Table 141 RoW Cancer Vaccines Market Outlook, By Antigen vaccines(2013-2022) ($MN)
Table 142 RoW Cancer Vaccines Market Outlook, By Dendritic Cell Vaccines (2013-2022) ($MN)
Table 143 RoW Cancer Vaccines Market Outlook, By Subunit Vaccines (2013-2022) ($MN)
Table 144 RoW Cancer Vaccines Market Outlook, By Heat shock protein vaccines (2013-2022) ($MN)
Table 145 RoW Cancer Vaccines Market Outlook, By DNA- and vector-based vaccines (2013-2022) ($MN)
Table 146 RoW Cancer Vaccines Market Outlook, By Conjugate Vaccines (2013-2022) ($MN)
Table 147 RoW Cancer Vaccines Market Outlook, By Anti-idiotype vaccines (2013-2022) ($MN)
Table 148 RoW Cancer Vaccines Market Outlook, By Cancer stem cell vaccines (2013-2022) ($MN)
Table 149 RoW Cancer Vaccines Market Outlook, By End User (2013-2022) ($MN)
Table 150 RoW Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)
Table 151 RoW Cancer Vaccines Market Outlook, By Pediatrics (2013-2022) ($MN)
Table 152 RoW Cancer Vaccines Market Outlook, By Vaccine Type (2013-2022) ($MN)
Table 153 RoW Cancer Vaccines Market Outlook, By Therapeutic Vaccines (2013-2022) ($MN)
Table 154 RoW Cancer Vaccines Market Outlook, By Preventive Vaccines (2013-2022) ($MN)
Table 155 RoW Cancer Vaccines Market Outlook, By Adults (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report